English

ONE Bio, Corp.

EDGAR

Quarterly report (10-Q) · filed 2011-11-21

34 filing records in this dataset, filed from 2007-04-03 to 2011-11-21. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

13.5 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 13540053 USD Source

Operating margin

22.67%

2011-09-30 · %

Exact inputs and evidence

Operating Income: 3068901 USD Source
Revenue: 13540053 USD Source

Operating cash flow

5.32 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 9845979 USD Source
Operating Cash Flow: 4526979 USD Source

Free cash flow

5.21 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 9845979 USD Source
Operating Cash Flow: 4526979 USD Source
Capital Expenditure: 1047152 USD Source
Capital Expenditure: 942740 USD Source

Cash and cash equivalents: 14.5 million USD 2011-09-30 Source
Exact value

14460740 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

53.9 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Revenue: 52296203 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 37347194 USD · 2010-01-01 – 2010-09-30 Source
Revenue: 12080252 USD · 2011-01-01 – 2011-03-31 Source
Revenue: 13339367 USD · 2011-04-01 – 2011-06-30 Source
Revenue: 13540053 USD · 2011-07-01 – 2011-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-11-21.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2010-12-31
Operating income: 3 of 11 periods available· newest 2010-12-31
Net income: 3 of 11 periods available· newest 2010-12-31
Operating cash flow: 3 of 11 periods available· newest 2010-12-31
Capital expenditure: 3 of 11 periods available· newest 2010-12-31
Total assets: 3 of 11 periods available· newest 2010-12-31
Total liabilities: 3 of 11 periods available· newest 2010-12-31
Current assets: 3 of 11 periods available· newest 2010-12-31
Current liabilities: 3 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+136.9%

Prior period

USD 22.07 million

2009-01-01 – 2009-12-31
Current period

USD 52.3 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

52296203 − 22073219 = 30222984 USD

22073219 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
52296203 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Year-over-year change in Revenue: 30222984 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 52296203 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#9961 Input fundies:Revenue: 22073219 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#9961
The citation records this snapshot. The page link may show a newer release later.
Net income
+66.3%

Prior period

USD 5.38 million

2009-01-01 – 2009-12-31
Current period

USD 8.96 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

8955176 − 5384973 = 3570203 USD

5384973 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
8955176 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Year-over-year change in Net income: 3570203 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 8955176 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10431 Input fundies:NetIncome: 5384973 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10431
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+105.2%

Prior period

USD 4.27 million

2009-01-01 – 2009-12-31
Current period

USD 8.76 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

8762907 − 4269910 = 4492997 USD

4269910 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
8762907 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Year-over-year change in Operating cash flow: 4492997 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 8762907 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10872 Input fundies:OperatingCashFlow: 4269910 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10872
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+342.1%

Prior period

USD 844,615

2009-01-01 – 2009-12-31
Current period

USD 3.73 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

3734130 − 844615 = 2889515 USD

844615 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
3734130 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Year-over-year change in Capital expenditure: 2889515 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3734130 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10906 Input fundies:CapitalExpenditure: 844615 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10906
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 52.3 million 100% of revenue
Cost of revenue USD 32.17 million 62% of revenue
Operating expenses USD 6.44 million 12% of revenue
Operating income USD 13.68 million 26% of revenue
Tax, interest and other Derived USD 4.73 million 9% of revenue
Net income USD 8.96 million 17% of revenue

Cash

Operating cash flow USD 8.76 million 17% of revenue
Capital expenditure USD 3.73 million 7.1% of revenue
Free cash flow Derived USD 5.03 million 9.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 32%13%55%
2009 24%9.4%66%
2010 17%9%74%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	10401530	5749734 Derived	4651796	1301497 Derived	3350299	1702852 Derived	Source 2008-01-01 – 2008-12-31: 10401530 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 4651796 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 3350299 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 1704438 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 1586 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	22073219	14614466 Derived	7458753	2073780 Derived	5384973	3425295 Derived	Source 2009-01-01 – 2009-12-31: 22073219 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 7458753 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 5384973 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 4269910 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 844615 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	52296203	38614654 Derived	13681549	4726373 Derived	8955176	5028777 Derived	Source 2010-01-01 – 2010-12-31: 52296203 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 13681549 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 8955176 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 8762907 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 3734130 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 52.3M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	10401530	Revenue: 10401530 Open source
20092009-12-31	Revenue	22073219	Revenue: 22073219 Open source
20102010-12-31	Revenue	52296203	Revenue: 52296203 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

136.9% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 10401530 Open source
20092009-12-31	Year over year	112.2%	Revenue: 22073219 Open source Revenue: 10401530 Open source
20102010-12-31	Year over year	136.9%	Revenue: 52296203 Open source Revenue: 22073219 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 26.2% 2010

Net margin 17.1% 2010

Free cash flow margin 9.6% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	44.7%	Operating Income: 4651796 Open source Revenue: 10401530 Open source
20092009-12-31	Operating margin	33.8%	Operating Income: 7458753 Open source Revenue: 22073219 Open source
20102010-12-31	Operating margin	26.2%	Operating Income: 13681549 Open source Revenue: 52296203 Open source
20082008-12-31	Net margin	32.2%	Net Income: 3350299 Open source Revenue: 10401530 Open source
20092009-12-31	Net margin	24.4%	Net Income: 5384973 Open source Revenue: 22073219 Open source
20102010-12-31	Net margin	17.1%	Net Income: 8955176 Open source Revenue: 52296203 Open source
20082008-12-31	Free cash flow margin	16.4%	Revenue: 10401530 Open source Operating Cash Flow: 1704438 Open source Capital Expenditure: 1586 Open source
20092009-12-31	Free cash flow margin	15.5%	Revenue: 22073219 Open source Operating Cash Flow: 4269910 Open source Capital Expenditure: 844615 Open source
20102010-12-31	Free cash flow margin	9.6%	Revenue: 52296203 Open source Operating Cash Flow: 8762907 Open source Capital Expenditure: 3734130 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 8.8M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	1704438	Operating Cash Flow: 1704438 Open source
20092009-12-31	Operating cash flow	4269910	Operating Cash Flow: 4269910 Open source
20102010-12-31	Operating cash flow	8762907	Operating Cash Flow: 8762907 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 5M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	1702852	Operating Cash Flow: 1704438 Open source Capital Expenditure: 1586 Open source
20092009-12-31	Free cash flow	3425295	Operating Cash Flow: 4269910 Open source Capital Expenditure: 844615 Open source
20102010-12-31	Free cash flow	5028777	Operating Cash Flow: 8762907 Open source Capital Expenditure: 3734130 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

39.2% 2010

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Liabilities / assets	14.9%	Total Liabilities: 2503157 Open source Total Assets: 16841811 Open source
20092009-12-31	Liabilities / assets	39.4%	Total Liabilities: 21551527 Open source Total Assets: 54633851 Open source
20102010-12-31	Liabilities / assets	39.2%	Total Liabilities: 27515850 Open source Total Assets: 70105545 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.48× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	2.21×	Current Assets: 5527024 Open source Current Liabilities: 2503157 Open source
20092009-12-31	Current assets / current liabilities	1.6×	Current Assets: 27518329 Open source Current Liabilities: 17234572 Open source
20102010-12-31	Current assets / current liabilities	1.48×	Current Assets: 39760450 Open source Current Liabilities: 26923652 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	USD 3.35 million Exact value Exact value: 3350299 USD 2008-01-01 – 2008-12-31: 3350299 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONE Bio, Corp. · 2008-12-31 ONE Bio, Corp. (edgar:1372267) Net Income: 3350299 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3350299 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001188112-10-002629.txt#10644 The citation records this snapshot. The page link may show a newer release later.	USD 1.7 million Exact value Exact value: 1704438 USD 2008-01-01 – 2008-12-31: 1704438 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONE Bio, Corp. · 2008-12-31 ONE Bio, Corp. (edgar:1372267) Operating Cash Flow: 1704438 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1704438 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001188112-10-002629.txt#11022 The citation records this snapshot. The page link may show a newer release later.	USD 1,586 Exact value Exact value: 1586 USD 2008-01-01 – 2008-12-31: 1586 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONE Bio, Corp. · 2008-12-31 ONE Bio, Corp. (edgar:1372267) Capital Expenditure: 1586 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1586 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001188112-10-002629.txt#11068 The citation records this snapshot. The page link may show a newer release later.	USD 1.7 million Calculation and evidence 1704438 − 1586 USD Exact free cash flow: 1702852 USD 2008-01-01 – 2008-12-31: 1704438 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 1586 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONE Bio, Corp. · 2008-12-31 ONE Bio, Corp. (edgar:1372267) Free cash flow: 1702852 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1704438 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001188112-10-002629.txt#11022 Input fundies:CapitalExpenditure: 1586 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001188112-10-002629.txt#11068 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 5.38 million Exact value Exact value: 5384973 USD 2009-01-01 – 2009-12-31: 5384973 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONE Bio, Corp. · 2009-12-31 ONE Bio, Corp. (edgar:1372267) Net Income: 5384973 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5384973 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10431 The citation records this snapshot. The page link may show a newer release later.	USD 4.27 million Exact value Exact value: 4269910 USD 2009-01-01 – 2009-12-31: 4269910 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONE Bio, Corp. · 2009-12-31 ONE Bio, Corp. (edgar:1372267) Operating Cash Flow: 4269910 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4269910 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10872 The citation records this snapshot. The page link may show a newer release later.	USD 844,615 Exact value Exact value: 844615 USD 2009-01-01 – 2009-12-31: 844615 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONE Bio, Corp. · 2009-12-31 ONE Bio, Corp. (edgar:1372267) Capital Expenditure: 844615 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 844615 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10906 The citation records this snapshot. The page link may show a newer release later.	USD 3.43 million Calculation and evidence 4269910 − 844615 USD Exact free cash flow: 3425295 USD 2009-01-01 – 2009-12-31: 4269910 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 844615 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONE Bio, Corp. · 2009-12-31 ONE Bio, Corp. (edgar:1372267) Free cash flow: 3425295 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4269910 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10872 Input fundies:CapitalExpenditure: 844615 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10906 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 8.96 million Exact value Exact value: 8955176 USD 2010-01-01 – 2010-12-31: 8955176 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Net Income: 8955176 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8955176 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10431 The citation records this snapshot. The page link may show a newer release later.	USD 8.76 million Exact value Exact value: 8762907 USD 2010-01-01 – 2010-12-31: 8762907 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Operating Cash Flow: 8762907 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8762907 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10872 The citation records this snapshot. The page link may show a newer release later.	USD 3.73 million Exact value Exact value: 3734130 USD 2010-01-01 – 2010-12-31: 3734130 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Capital Expenditure: 3734130 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3734130 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10906 The citation records this snapshot. The page link may show a newer release later.	USD 5.03 million Calculation and evidence 8762907 − 3734130 USD Exact free cash flow: 5028777 USD 2010-01-01 – 2010-12-31: 8762907 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 3734130 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONE Bio, Corp. · 2010-12-31 ONE Bio, Corp. (edgar:1372267) Free cash flow: 5028777 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:39:28Z Snapshot: 111c1eb6e970abe4faad9e7a32d73ad007ba119f2174b9c73618b44d3fb9da1f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372267?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8762907 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10872 Input fundies:CapitalExpenditure: 3734130 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372267/0001354488-11-001040.txt#10906 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001372267, 1372267, edgar:1372267

Also known as Contracted Services, Inc., ONE Holdings, Corp.

ONE Bio, Corp.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation